Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05416567

Embolization for Meningioma

Therapeutic Endovascular Embolization for Intracranial Meningioma

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
St. Olavs Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The natural course for meningioma suggests that a majority will grow over time. Treatment is usually indicated in growing or symptomatic meningiomas. Surgery is usually primary treatment, but there is a significant risk of adverse effects. Stereotactic radiotherapy is most often reserved to treat relapses after surgery, and except for surgery and radiotherapy there are no other established treatment methods. Endovascular embolization may be used in selected cases as a preoperative adjunct to reduce intraoperative bleeding. There is a need for more treatment options in patients with meningioma, both in uncomplicated, asymptomatic cases and in more complex cases. The aim of this study is to assess radiological and clinical results of therapeutic endovascular embolization for meningioma

Conditions

Interventions

TypeNameDescription
PROCEDUREEndovascular embolizationTherapeutic endovascular embolization in general anesthesia

Timeline

Start date
2022-10-10
Primary completion
2027-08-01
Completion
2037-08-01
First posted
2022-06-13
Last updated
2025-06-05

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT05416567. Inclusion in this directory is not an endorsement.